Table 4.
Predictors of OAT prescription at discharge in the whole sample, before, and after the guideline.
| Whole sample | Period: | |||||
| 2000 | 2004 | |||||
| OR* | (95% CI) | OR* | (95% CI) | OR* | (95% CI) | |
| Risk of stroke: | ||||||
| ▪ Moderate | 1 | - | 1 | - | 1 | - |
| ▪ High | 0.99 | (0.55 – 1.76) | 0.45 | (0.19 – 1.03) | 2.18 | (0.96 – 4.94) |
| ▪ Very high | 1.48 | (0.78 – 2.80) | 0.58 | (0.23 – 1.44) | 3.92 | (1.55 – 9.93) |
| Contraindications to OAT: | ||||||
| ▪ None | 1 | - | 1 | - | 1 | - |
| ▪ One or more | 0.18 | (0.13 – 0.27) | 0.17 | (0.09 – 0.34) | 0.19 | (0.11 – 0.30) |
| Age: | ||||||
| ▪ < 75 | 1 | - | 1 | - | 1 | - |
| ▪ ≥ 75 | 0.30 | (0.21 – 0.45) | 0.35 | (0.19 – 0.62) | 0.26 | (0.15 – 0.43) |
| AT at admission: | ||||||
| ▪ No | 1 | - | 1 | - | 1 | - |
| ▪ Yes | 3.03 | (2.08 – 4.43) | 4.88 | (2.74 – 8.69) | 2.07 | (1.23 – 3.47) |
| Period: | ||||||
| ▪ 2000 | 1 | - | - | - | - | - |
| ▪ 2004 | 2.11 | (1.47 – 3.04) | - | - | - | - |
(*)Odds ratios (OR) and 95% confidence intervals (95% CI) adjusted for all the variables listed in the table with logistic regression models.
OAT, oral anticoagulant therapy; AT, antithrombotic therapy.